CAESARSTONE LTD (CSTE) Stock Fundamental Analysis
USA - NASDAQ:CSTE - IL0011259137 - Common Stock
0.99 USD
0 (0%)
Taking everything into account, CSTE scores 1 out of 10 in our fundamental rating. CSTE was compared to 41 industry peers in the Building Products industry. While CSTE seems to be doing ok healthwise, there are quite some concerns on its profitability. CSTE is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CSTE had negative earnings in the past year.
CSTE had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CSTE reported negative net income in multiple years.
CSTE had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
CSTE has a worse Return On Assets (-10.62%) than 80.49% of its industry peers.
CSTE's Return On Equity of -22.29% is on the low side compared to the rest of the industry. CSTE is outperformed by 75.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.62% | ||
| ROE | -22.29% | ||
| ROIC | N/A |
ROA(3y)-11.12%
ROA(5y)-6.06%
ROE(3y)-20.4%
ROE(5y)-11.19%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of CSTE (20.04%) is worse than 73.17% of its industry peers.
CSTE's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CSTE so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.44%
GM growth 5Y-4.33%
2. Health
2.1 Basic Checks
CSTE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CSTE remains at a similar level compared to 1 year ago.
The number of shares outstanding for CSTE has been increased compared to 5 years ago.
CSTE has a better debt/assets ratio than last year.
2.2 Solvency
CSTE has an Altman-Z score of 1.31. This is a bad value and indicates that CSTE is not financially healthy and even has some risk of bankruptcy.
CSTE has a Altman-Z score of 1.31. This is amonst the worse of the industry: CSTE underperforms 90.24% of its industry peers.
CSTE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CSTE (0.00) is better than 92.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.31 |
ROIC/WACCN/A
WACC8.44%
2.3 Liquidity
A Current Ratio of 2.17 indicates that CSTE has no problem at all paying its short term obligations.
The Current ratio of CSTE (2.17) is better than 63.41% of its industry peers.
CSTE has a Quick Ratio of 1.40. This is a normal value and indicates that CSTE is financially healthy and should not expect problems in meeting its short term obligations.
CSTE has a Quick ratio of 1.40. This is in the better half of the industry: CSTE outperforms 68.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.17 | ||
| Quick Ratio | 1.4 |
3. Growth
3.1 Past
The earnings per share for CSTE have decreased strongly by -73.42% in the last year.
The Revenue for CSTE has decreased by -21.59% in the past year. This is quite bad
The Revenue has been decreasing by -4.09% on average over the past years.
EPS 1Y (TTM)-73.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-21.59%
Revenue growth 3Y-11.71%
Revenue growth 5Y-4.09%
Sales Q2Q%-5.13%
3.2 Future
CSTE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -8.91% yearly.
Based on estimates for the next years, CSTE will show a decrease in Revenue. The Revenue will decrease by -3.73% on average per year.
EPS Next Y-42.33%
EPS Next 2Y-8.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-12.25%
Revenue Next 2Y-3.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CSTE. In the last year negative earnings were reported.
Also next year CSTE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as CSTE's earnings are expected to decrease with -8.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.91%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for CSTE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:CSTE (11/17/2025, 8:00:01 PM)
0.99
0 (0%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst Owners30.23%
Inst Owner Change-9.18%
Ins Owners1.65%
Ins Owner ChangeN/A
Market Cap34.22M
Revenue(TTM)443.22M
Net Income(TTM)-56.22M
Analysts82.86
Price Target4.08 (312.12%)
Short Float %0.22%
Short Ratio0.63
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-34.29%
Min EPS beat(2)-79.74%
Max EPS beat(2)11.15%
EPS beat(4)1
Avg EPS beat(4)-39.05%
Min EPS beat(4)-79.74%
Max EPS beat(4)11.15%
EPS beat(8)3
Avg EPS beat(8)-26.84%
EPS beat(12)3
Avg EPS beat(12)-238.09%
EPS beat(16)5
Avg EPS beat(16)-178.38%
Revenue beat(2)1
Avg Revenue beat(2)-3.32%
Min Revenue beat(2)-7.26%
Max Revenue beat(2)0.62%
Revenue beat(4)1
Avg Revenue beat(4)-5.47%
Min Revenue beat(4)-11.77%
Max Revenue beat(4)0.62%
Revenue beat(8)2
Avg Revenue beat(8)-5.6%
Revenue beat(12)2
Avg Revenue beat(12)-6.31%
Revenue beat(16)3
Avg Revenue beat(16)-4.6%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-52.63%
EPS NY rev (1m)0%
EPS NY rev (3m)-41.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.74%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.08 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.14 | ||
| P/tB | 0.14 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.37
EYN/A
EPS(NY)-1.02
Fwd EYN/A
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS11.75
BVpS7.3
TBVpS7.29
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.62% | ||
| ROE | -22.29% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.04% | ||
| FCFM | N/A |
ROA(3y)-11.12%
ROA(5y)-6.06%
ROE(3y)-20.4%
ROE(5y)-11.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.44%
GM growth 5Y-4.33%
F-Score3
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 73.43% | ||
| Cap/Sales | 2.8% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.17 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 1.31 |
F-Score3
WACC8.44%
ROIC/WACCN/A
Cap/Depr(3y)49.02%
Cap/Depr(5y)60.64%
Cap/Sales(3y)2.3%
Cap/Sales(5y)3.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
EPS Next Y-42.33%
EPS Next 2Y-8.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.59%
Revenue growth 3Y-11.71%
Revenue growth 5Y-4.09%
Sales Q2Q%-5.13%
Revenue Next Year-12.25%
Revenue Next 2Y-3.73%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-72.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year32.38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-245.64%
FCF growth 3YN/A
FCF growth 5Y-18.43%
OCF growth 1Y-139.84%
OCF growth 3Y15.48%
OCF growth 5Y-17.42%
CAESARSTONE LTD / CSTE FAQ
What is the ChartMill fundamental rating of CAESARSTONE LTD (CSTE) stock?
ChartMill assigns a fundamental rating of 1 / 10 to CSTE.
What is the valuation status for CSTE stock?
ChartMill assigns a valuation rating of 0 / 10 to CAESARSTONE LTD (CSTE). This can be considered as Overvalued.
What is the profitability of CSTE stock?
CAESARSTONE LTD (CSTE) has a profitability rating of 1 / 10.
What is the expected EPS growth for CAESARSTONE LTD (CSTE) stock?
The Earnings per Share (EPS) of CAESARSTONE LTD (CSTE) is expected to decline by -42.33% in the next year.
Can you provide the dividend sustainability for CSTE stock?
The dividend rating of CAESARSTONE LTD (CSTE) is 0 / 10 and the dividend payout ratio is 0%.